Composition
- Active ingredients
- DOXYCYCLINE HYCLATE EQ 100MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DOXYCYCLINE HYCLATE EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseNDA050795-006 · Discontinued
- DOXYCYCLINE HYCLATE EQ 80MG BASE · Tablet, delayed releaseNDA050795-004 · Discontinued
- DOXYCYCLINE HYCLATE EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseNDA050795-002 · Discontinued
- DOXYCYCLINE HYCLATE EQ 200MG BASE · Tablet, delayed releaseNDA050795-005 · Discontinued
- DOXYCYCLINE HYCLATE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseNDA050795-003 · Discontinued
- DOXYCYCLINE HYCLATE EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, delayed releaseNDA050795-001 · Discontinued
- DOXYCYCLINE HYCLATE EQ 100MG BASE · Capsule, delayed releaseThis page
- DOXYCYCLINE HYCLATE EQ 75MG BASE · Capsule, delayed releaseNDA050582-002 · Discontinued
- DOXYCYCLINE HYCLATE EQ 100MG BASE · Capsule, delayed releaseANDA062653-001 · Discontinued
At a glance
- Brand name
- Doryx
- Active substance
- doxycycline hyclate
- Route
- Oral
- Dosage form
- Capsule, delayed release
- Applicant
- Mayne Pharma
- Status
- Discontinued
- FDA approval
- 22 Jul 1985
- Application
- NDA050582-001